| Item Type | Name |
|
Academic Article
|
Neurological deficits during treatment with tumor necrosis factor-alpha antagonists.
|
|
Academic Article
|
The United States to Africa lupus prevalence gradient revisited.
|
|
Academic Article
|
IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus.
|
|
Academic Article
|
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
|
|
Academic Article
|
Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members.
|
|
Academic Article
|
Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus.
|
|
Concept
|
Antibodies, Anticardiolipin
|
|
Concept
|
Antibodies, Antinuclear
|
|
Concept
|
Antibodies, Antiphospholipid
|
|
Concept
|
Antibodies, Viral
|
|
Concept
|
Antibodies, Anti-Idiotypic
|
|
Concept
|
Antibodies, Monoclonal
|
|
Academic Article
|
Spatial environmental modeling of autoantibody outcomes among an African American population.
|
|
Academic Article
|
Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA.
|
|
Academic Article
|
Anti-C1q antibodies in systemic lupus erythematosus.
|
|
Academic Article
|
Smoking is not associated with autoantibody production in systemic lupus erythematosus patients, unaffected first-degree relatives, nor healthy controls.
|
|
Academic Article
|
Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Vitamin D3 on the Interferon Signature in Patients With Systemic Lupus Erythematosus.
|
|
Academic Article
|
Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of ?2-glycoprotein I.
|
|
Academic Article
|
Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production.
|
|
Academic Article
|
Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices.
|
|
Academic Article
|
Developing and Refining New Candidate Criteria for Systemic Lupus Erythematosus Classification: An International Collaboration.
|
|
Academic Article
|
Antiphospholipid Antibodies and Heart Valve Disease in Systemic Lupus Erythematosus.
|
|
Academic Article
|
Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.
|
|
Academic Article
|
Psychosis in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
|
|
Academic Article
|
Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria.
|
|
Academic Article
|
Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial.
|
|
Academic Article
|
A Link Between Plasma Microbial Translocation, Microbiome, and Autoantibody Development in First-Degree Relatives of Systemic Lupus Erythematosus Patients.
|
|
Academic Article
|
Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals.
|
|
Academic Article
|
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.
|
|
Academic Article
|
European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance.
|
|
Academic Article
|
Anti-beta 2 glycoprotein I IgA in the SLICC classification criteria dataset.
|
|
Academic Article
|
Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.
|
|
Concept
|
Antibodies, Monoclonal, Humanized
|
|
Academic Article
|
Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
|
|
Academic Article
|
Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus.
|